MO HB3357

Prohibits sale or distribution of intravenous solution containers made with intentionally added DEHP (di(2-ethylhexyl) phthalate) beginning January 1, 2030

Prohibits manufacture, sale, or distribution of intravenous tubing made with intentionally added DEHP beginning January 1, 2035

Bans replacing DEHP with any other ortho-phthalate chemical in new or revised medical devices, and limits unintentionally added DEHP to below 0.1% weight per weight

Exempts human blood collection and storage bags, as well as apheresis and cell therapy blood kits and bags with integral tubing

Allows a 2-year extension (to January 1, 2032) for IV solution container compliance if pending FDA approval or equipment issues exist, provided manufacturers notify Missouri customers by October 1, 2026 and publicly announce the delay by January 1, 2028